Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University, through its innovation arm Oxford University Innovation (OUI), is launching support for the creation of impact-driven businesses: social enterprises.

Social enterprises are companies which combine the impact-centric agenda of a charity with the profit generation strategies of a business. How this is achieved differs from company to company, but fundamental to all social enterprise is the concept of replacing the profitability goal at the core of mainstream businesses with an impact mission focused on enacting positive societal or environmental change.

To date, the innovation side of the University has supported creation of two types of business: regular startup businesses created by the student body, and ventures based on intellectual property from the University supported by OUI, known as spinouts. Typically, spinouts are formed around a patentable technology, such as a potential therapeutic candidate or an engineering project. This model has been successful for turning Oxford research into reality, with the University creating over 160 spinout companies since OUI opened its doors in 1987, 19 of which were launched in the past year.

Find out more (University of Oxford website)

Similar stories

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.